Human microRNA hsa-miR-125a-5p interferes with expression of hepatitis B virus surface antigen

Nucleic Acids Research

Volumn 39, Issue 12, 2011, Pages 5157-5163

  Potenza, Nicoletta ^a   Papa, Umberto ^a   Mosca, Nicola ^a   Zerbini, Francesca ^a   Nobile, Valentina ^a   Russo, Aniello ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; HEPATITIS B SURFACE ANTIGEN; HSA MIR 125A 5P; LUCIFERASE; MICRORNA; RNA POLYMERASE; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DOWN REGULATION; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE INTERACTION; GENE REPRESSION; GENE SILENCING; GENETIC CONSERVATION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PLASMID; PRIORITY JOURNAL; RESTRICTION SITE; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS TRANSCRIPTION;

CELL LINE, TUMOR; GENOME, VIRAL; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LIVER; MICRORNAS; PROTEIN BIOSYNTHESIS; RNA INTERFERENCE;

HEPATITIS B VIRUS; MAMMALIA;

EID: 79960236156     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkr067     Document Type: Article

References (42)

1. Ambros, V. (2004) The functions of animal microRNAs. Nature, 431, 350-355. (Pubitemid 39265675)
2. Griffiths-Jones, S., Saini, H.K., van Dongen, S., Bateman, A. and Enright, A.J. (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res., 36, D154-D158. (Pubitemid 351149713)
3. Lewis, B.P., Burge, C.B. and Bartel, D.P. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120, 15-20. (Pubitemid 40094598)
4. Bartel, D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-297.
5. Wienholds, E. and Plasterk, R.H. (2005) MicroRNA function in animal development. FEBS Lett., 579, 5911-5922. (Pubitemid 41487106)
6. Esquela-Kerscher, A. and Slack, F.J. (2006) Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer, 6, 259-269.
7. Lu, J., Getz, G., Miska, E.A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B.L., Mak, R.H., Ferrando, A.A. et al. (2005) MicroRNA expression profiles classify human cancers. Nature, 435, 834-838. (Pubitemid 40839735)
8. Hammond, S.M. (2005) Dicing and slicing: the core machinery of the RNA interference pathway. FEBS Lett., 579, 5822-5829. (Pubitemid 41484128)
9. Ma, J.B., Yuan, Y.R., Meister, G., Pei, Y., Tuschl, T. and Patel, D.J. (2005) Structural basis for 50-end-specific recognition of guide RNA by the A. fulgidus Piwi protein. Nature, 434, 666-670. (Pubitemid 40488561)
10. Kim, V.N. (2005) MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell Biol., 6, 376-385. (Pubitemid 40637855)
11. Eulalio, A., Huntzinger, E. and Izaurralde, F. (2008) Getting to the root of miRNA-mediated gene silencing. Cell, 132, 9-14.
12. Hamilton, A.J. and Baulcombe, D.C. (1999) A species of small antisense RNA in posttranscriptional gene silencing in plants. Science, 286, 950-952.
13. Li, H., Li, W.X. and Ding, S.W. (2002) Induction and suppression of RNA silencing by an animal virus. Science, 296, 1319-1321. (Pubitemid 34522787)
14. Pichlmair, A. and Reis e Sousa, C. (2007) Innate recognition of viruses. Immunity, 27, 370-383. (Pubitemid 47418682)
15. Lecellier, C.H., Dunoyer, P., Arar, K., Lehmann-Che, J., Eyquem, S., Himber, C., Saib, A. and Voinnet, O. (2005) A cellular microRNA mediates antiviral defense in human cells. Science, 308, 557-560. (Pubitemid 40570587)
16. Pedersen, I.M., Cheng, G., Wieland, S., Volinia, S., Croce, C.M., Chisari, F.V. and David, M. (2007) Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature, 449, 919-922. (Pubitemid 47598616)
17. Otsuka, M., Jing, Q., Georgel, P., New, L., Chen, J., Mols, J., Kang, Y.J., Jiang, Z., Du, X., Cook, R. et al. (2007) Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression. Immunity, 27, 123-134. (Pubitemid 47089021)
18. Huang, J., Wang, F., Argyris, E., Chen, K., Liang, Z., Tian, H., Huang, W., Squires, K., Verlinghieri, G. and Zhang, H. (2007) Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+T lymphocytes. Nat. Med., 13, 1241-1247. (Pubitemid 47530631)
19. Nuovo, G.J., Wu, X., Volinia, S., Yan, F., di Leva, G., Chin, N., Nicol, A.F., Jiang, J., Otterson, G., Schmittgen, T.D. et al. (2010) Strong inverse correlation between microRNA-125b and human papillomavirus DNA in productive infection. Diagn. Mol. Pathol., 19, 135-143.
20. Hsu, P.W., Lin, L.Z., Hsu, S.D., Hsu, J.B. and Huang, H.D. (2007) ViTa: prediction of host microRNAs targets on viruses. Nucleic Acids Res., 35, D381-D385. (Pubitemid 46056236)
21. Ghosh, Z., Mallick, B. and Chakrabarti, J. (2009) Cellular versus viral microRNAs in host-virus interaction. Nucleic Acids Res., 37, 1035-1048.
22. Mahajan, V.S., Drake, A. and Chen, J. (2009) Virus-specific host miRNAs: antiviral defenses or promoters of persistent infection? Trends Immunol., 30, 1-7.
23. Chin, R. and Locarnini, S. (2003) Treatment of chronic hepatitis B: current challenges and future directions. Rev. Med. Virol., 13, 255-272. (Pubitemid 36875194)
24. John, B., Enright, A.J., Aravin, A., Tuschl, T., Sander, C. and Marks, D.S. (2004) Human microRNA targets. PLoS Biol., 2, e363.
25. Potenza, N., Moggio, L., Milano, G., Salvatore, V., Di Blasio, B., Russo, A. and Messere, A. (2008) RNA interference in mammalian cells by RNA-30-PNA chimeras. Int. J. Mol. Sci., 9, 299-315. (Pubitemid 351482116)
26. Gururajan, M., Haga, C.L., Das, S., Leu, C.M., Hodson, D., Josson, S., Turner, M. and Cooper, M.D. (2010) MicroRNA 125b inhibition of B cell differentiation in germinal centers. Int. Immunol., 22, 583-592.
27. Ganem, D. and Varmus, H.E. (1987) The molecular biology of the hepatitis B viruses. Annu. Rev. Biochem., 56, 651-693.
28. Crouch, R.J. (2005) Ribonuclease H: from discovery to 3D structure. New Biol., 2, 771-777.
29. Kuhn, D.E., Martin, M.M., Feldman, D.S., Terry, A.V. Jr, Nuovo, G.J. and Elton, T.S. (2008) Experimental validation of miRNA targets. Methods, 44, 47-54. (Pubitemid 350297983)
30. Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A.O., Landthaler, M. et al. (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell, 129, 1401-1414. (Pubitemid 46970709)
31. Liu, Y., Zhao, J.J., Wang, C.M., Li, M.Y., Han, P., Wang, L., Cheng, Y.Q., Zoulim, F., Ma, X. and Xu, D.P. (2009) Altered expression profiles of microRNAs in a stable hepatitis B virus-expressing cell line. Chin. Med. J., 122, 10-14.
32. Scott, G.K., Goga, A., Bhaumik, D., Berger, C.E., Sullivan, C.S. and Christofer, C.B. (2007) Coordinate Suppression of ERBB2 and ERBB3 by Enforced Expression of Micro-RNA miR-125a or miR-125b. J. Biol. Chem., 282, 1479-1486. (Pubitemid 47076526)
33. Zhang, Y., Gao, J.S., Tang, X., Tucker, L.D., Quesenberry, P., Rigoutsos, I. and Ramratnam, B. (2009) MicroRNA 125a and its regulation of the p53 tumor suppressor gene. FEBS Lett., 583, 3725-3730.
34. Wang, Y., Lu, Y., Toh, S.T., Sung, W., Tan, P., Chow, P., Chung, A.Y.F., Jooi, L.L.P. and Lee, C.G.L. (2010) Lethal-7 is down-regulated by the hepatitis B virus X protein and targets signal transducer and activator of transcription 3. J. Hepatol., 53, 57-66.
35. MacNab, G.M., Alexander, J.J., Lecatsas, G., Bey, E.M. and Urbanowicz, J.M. (1976) Hepatitis B surface antigen produced by a human hepatoma cell line. Br. J. Cancer, 34, 509-515.
36. Radziwill, G., Tucker, W. and Schaller, H. (1990) Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity. J. Virol., 64, 613-620. (Pubitemid 20032673)
37. Yatsuji, H., Noguchi, C., Hiraga, N., Mori, N., Tsuge, M., Imamura, M., Takahashi, S., Iwao, E., Fujimoto, Y., Ochi, H. et al. (2006) Emergence of a novel lamivudine-resistant hepatitis B virus variant with a substitution outside the YMDD motif. Antimicrob. Agents Chemother., 50, 3867-3874. (Pubitemid 44684905)
38. Le Duff, Y., Blanchet, M. and Sureau, C. (2009) The pre-S1 and antigenic loop infectivity determinants of the hepatitis B virus envelope proteins are functionally independent. J. Virol., 83, 12443-12451.
39. Seeger, C. and Mason, W.S. (2000) Hepatitis B virus biology. Microbiol. Mol. Biol. Rev., 64, 51-68. (Pubitemid 30143840)
40. Zoulim, F. (1999) Therapy of chronic hepatitis B virus infection: inhibition of the viral polymerase and other antiviral strategies. Antiviral Res., 44, 1-30. (Pubitemid 29505328)
41. Feld, J., Lee, J.Y. and Locarnini, S. (2003) New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B. Hepatology, 38, 545-553. (Pubitemid 37052140)
42. Xiangji, L., Feng, X., Qingbao, C., Weifeng, T., Xiaoqing, J., Baihe, Z., Feng, S., Hongyang, W. and Mengchao, W. (2010) Knockdown of HBV surface antigen gene expression by a lentiviral microRNA-based system inhibits HBV replication and HCC growth. J. Viral Hepat., doi:10.1111/j.1365-2893.2010.01346.x [Epub ahead of print, 19 July 2010].